Having trouble accessing articles? Reset your cache.

Peretinoin: Phase II/III data

In a double-blind, Japanese Phase II/III trial in 401 HCV-positive HCC patients who underwent curative

Read the full 151 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE